Beth C. Seidenberg

Insider Reports History

Location
Westlake Village, CA
Signature
By: /s/ Jennifer L. Kercher, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Beth C. Seidenberg:

Form 4 holding Director

Progyny, Inc.

Security class
Common Stock
Shares / value
227,906
Estimated value
$7,281,597
Report date
23 May 2024
Price
$31.95
Ownership
Indirect
Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
131,553
Estimated value
$6,517,215
Report date
28 Oct 2024
Price
$49.54
Ownership
Direct
Form 4 holding Director

Progyny, Inc.

Security class
Common Stock
Shares / value
43,416
Estimated value
$1,387,141
Report date
23 May 2024
Price
$31.95
Ownership
Direct
Form 4 holding Director

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
4,012
Estimated value
$198,757
Report date
28 Oct 2024
Price
$49.54
Ownership
Indirect
Form 4 holding Director

Atara Biotherapeutics, Inc.

Security class
Non-Qualified Stock Option (Right to Buy)
Shares / value
79,500
Estimated value
Report date
31 May 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Progyny, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
26,926
Estimated value
Report date
23 May 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

ACELYRIN, Inc.

Security class
Director Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
21 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Beth C. Seidenberg

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .